- Filed
- May 13, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 30, 2026 | 19.91M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 19.5M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 17.2M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $8.7M |
| Capex | Q1 2026 · Mar 31, 2025 | $15M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $300K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$37.6M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $271.3M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $253.9M |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $500K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $5.6M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $5.7M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$96.1M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$74.2M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | −$26.6M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | −$10.5M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $123M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $126.2M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $154.1M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $149.9M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $331.5M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $340.3M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$1.23 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$1.62 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$1.23 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$1.62 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $15.4M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $21.6M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $400K |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $400K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$24M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$27.9M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$12.1M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$16.5M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $119.1M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $123.8M |
| Revenue | Q1 2026 · Mar 31, 2026 | $144.7M |
| Revenue | Q1 2026 · Mar 31, 2025 | $154M |